Giulia Bottoni
About Giulia Bottoni
Giulia Bottoni is a Senior Scientist I at MOMA Therapeutics, specializing in cancer research with expertise in high-throughput technologies. She has a PhD in Oncology and Cancer Biology from the University of Lausanne and has held various research positions at notable institutions including Harvard Medical School and Massachusetts General Hospital.
Current Role at MOMA Therapeutics
Giulia Bottoni serves as a Senior Scientist I at MOMA Therapeutics, a position she has held since 2022. In this role, she applies her expertise in high-throughput technologies to advance cancer research initiatives. Her work focuses on developing innovative therapeutic strategies to address cancer challenges. MOMA Therapeutics is known for its commitment to pioneering drug discovery, and Bottoni's contributions are integral to the company's research objectives.
Previous Experience at Harvard Medical School and Massachusetts General Hospital
Prior to her current role, Giulia Bottoni worked as a Research Fellow at Harvard Medical School and Massachusetts General Hospital from 2019 to 2020. During this year, she conducted significant research in the Greater Boston Area, contributing to the understanding of cancer biology. Before this, she served as a PhD Researcher at Massachusetts General Hospital from 2014 to 2018, where she focused on genetic and gene expression changes in squamous cell carcinoma-associated stroma.
Educational Background in Oncology and Cancer Biology
Giulia Bottoni earned her Doctor of Philosophy (PhD) in Oncology and Cancer Biology from the University of Lausanne (UNIL) between 2015 and 2018. Her doctoral research concentrated on novel mechanisms of cancer and tumor microenvironment interaction. She also holds a Bachelor's degree and a Master's degree in Cellular and Molecular Biology from Università degli Studi di Torino, completed between 2009 and 2014.
Experience in Pharmaceutical Research
Giulia Bottoni has held various roles in the pharmaceutical sector, including positions at Servier Pharmaceuticals and Agios Pharmaceuticals. At Servier, she worked as a Scientist from 2021 to 2022, focusing on cancer-related research in Boston. Prior to that, she was a Scientist at Agios Pharmaceuticals from 2020 to 2021, where she contributed to projects aimed at developing targeted therapies for cancer treatment.
Research Skills and Expertise
Giulia Bottoni possesses extensive expertise in high-throughput technologies, which are essential for advancing cancer research. She is skilled in microscopy and histology, allowing for detailed cellular and tissue analysis. Her research experience includes conducting studies on genetic changes in cancer-associated stroma and investigating interactions within the tumor microenvironment, which are critical for understanding cancer progression.